Does SBRT improve the Pembrolizumab response rate?

Multisite stereotactic body radiotherapy followed by PD-1 inhibition with pembrolizumab may be an effective option for some patients with advanced solid tumours, according to a study published in the Journal of Clinical Oncology.
Cancer Therapy Advisor